497 PTT-4256 is a first-in-class small molecule inhibitor of GPR65 that counteracts the low pH-dependent immunosuppressive effects on immune cells and displays pronounced anti-tumor activity in mice
Main Authors: | David Miller, Alastair Corbin, Barbara Young, Preeti Singh, Tobias Bopp, Darryl Turner, Barbara Cipriani, Alan Naylor, Gavin Milne, Rupert Satchell, Mussa Quareshy, Sourav Sarkar, Tobias Moechel, Philip MacFaul, Stuart Paine, Oliver Horne, Jessica Holien, Anastasia Nika, Gavin Knox, Toszka Bohn, Tom McCarthy, Stuart Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
4256 Association Between Injury Intent and Emergency Department and Hospital Charges for Pediatric Firearm Injuries in the United States
by: Diana Marie Bongiorno, et al.
Published: (2020-06-01) -
Shakespeare and the Natural World
by: MacFaul, T
Published: (2015) -
Learning to read: developing processes for recognizing, understanding and pronouncing written words
by: Morag Stuart
Published: (2006-02-01) -
Sclerosing cholangitis.
by: MacFaul, G, et al.
Published: (2004) -
Sclerosing cholangitis.
by: MacFaul, G, et al.
Published: (2006)